AST-120 in Hemodialysis Patients With Uremic Pruritus (AST-120)
Prospective Randomized Study Evaluating the Efficacy of the Spherical Absorptive Carbon AST-120 in Hemodialysis Patients With Uremic Pruritus..
Sponsor: Chang Gung Memorial Hospital
This PHASE4 trial investigates Uremic Pruritus and is currently completed. Chang Gung Memorial Hospital leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed · Phase: NA → PHASE4
-
Jul 2022 — Oct 2023 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
- Conmed Pharmaceutical & Bio-Medical Corporation
- Fu Jen Catholic University
- Kaohsiung Medical University
- Taichung Tzu Chi Hospital
- Taichung Veterans General Hospital
- Tri-Service General Hospital
- Tungs' Taichung Metroharbour Hospital
For direct contact, visit the study record on ClinicalTrials.gov .